Evo Fund raises stake in Delta-Fly Pharma to 22.55%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-10-08 10:51 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 22.55%, previous report: 20.65%.